Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Blood Vessel Prosthesis | 45 | 2024 | 957 | 2.390 |
Why?
|
Veins | 29 | 2017 | 768 | 1.970 |
Why?
|
Ischemia | 35 | 2017 | 1900 | 1.740 |
Why?
|
Leg | 40 | 2003 | 1088 | 1.710 |
Why?
|
Polyethylene Terephthalates | 22 | 2014 | 112 | 1.690 |
Why?
|
Muscle, Smooth, Vascular | 14 | 2016 | 1493 | 1.620 |
Why?
|
RNA, Small Interfering | 15 | 2024 | 3434 | 1.510 |
Why?
|
Diabetic Angiopathies | 29 | 2013 | 806 | 1.480 |
Why?
|
Myocytes, Smooth Muscle | 6 | 2024 | 703 | 1.420 |
Why?
|
Foot | 21 | 2005 | 577 | 1.120 |
Why?
|
Saphenous Vein | 20 | 2010 | 519 | 1.000 |
Why?
|
Gene Silencing | 6 | 2016 | 1503 | 0.970 |
Why?
|
Hirudins | 9 | 2024 | 179 | 0.950 |
Why?
|
Aorta | 9 | 2016 | 2046 | 0.900 |
Why?
|
Peripheral Vascular Diseases | 12 | 2007 | 489 | 0.880 |
Why?
|
Vascular Surgical Procedures | 26 | 2007 | 1515 | 0.870 |
Why?
|
Biocompatible Materials | 11 | 2010 | 1704 | 0.840 |
Why?
|
Angioplasty | 4 | 2017 | 357 | 0.830 |
Why?
|
Arteries | 17 | 2017 | 1126 | 0.820 |
Why?
|
Diabetes Complications | 17 | 2007 | 1322 | 0.800 |
Why?
|
Femoral Artery | 29 | 2007 | 829 | 0.770 |
Why?
|
Limb Salvage | 8 | 2017 | 489 | 0.750 |
Why?
|
Endothelium, Vascular | 17 | 2012 | 4427 | 0.750 |
Why?
|
Transfection | 7 | 2024 | 5764 | 0.750 |
Why?
|
Arterial Occlusive Diseases | 18 | 2006 | 746 | 0.720 |
Why?
|
Arteriosclerosis | 16 | 2002 | 1056 | 0.670 |
Why?
|
Vascular Patency | 29 | 2024 | 916 | 0.670 |
Why?
|
Arm | 13 | 2000 | 590 | 0.670 |
Why?
|
Blood Vessel Prosthesis Implantation | 19 | 2024 | 1459 | 0.660 |
Why?
|
Lower Extremity | 7 | 2024 | 1218 | 0.630 |
Why?
|
Diabetic Neuropathies | 13 | 2015 | 411 | 0.610 |
Why?
|
Diabetic Foot | 11 | 2005 | 383 | 0.610 |
Why?
|
Popliteal Artery | 19 | 2006 | 313 | 0.600 |
Why?
|
Tunica Intima | 9 | 2014 | 459 | 0.580 |
Why?
|
Polyurethanes | 6 | 2005 | 110 | 0.580 |
Why?
|
Ciprofloxacin | 7 | 2010 | 313 | 0.580 |
Why?
|
Wound Healing | 10 | 2015 | 2813 | 0.570 |
Why?
|
Graft Occlusion, Vascular | 14 | 2005 | 538 | 0.540 |
Why?
|
Thrombospondins | 3 | 2024 | 195 | 0.540 |
Why?
|
Carotid Stenosis | 6 | 2008 | 862 | 0.530 |
Why?
|
RNA Interference | 5 | 2014 | 2836 | 0.520 |
Why?
|
Hyperplasia | 15 | 2024 | 1153 | 0.500 |
Why?
|
Endarterectomy, Carotid | 6 | 2003 | 557 | 0.500 |
Why?
|
Stents | 7 | 2017 | 3201 | 0.490 |
Why?
|
Neuropeptides | 5 | 2013 | 950 | 0.470 |
Why?
|
Carotid Arteries | 11 | 2002 | 943 | 0.470 |
Why?
|
Polytetrafluoroethylene | 12 | 2002 | 245 | 0.470 |
Why?
|
Polyethyleneimine | 2 | 2016 | 68 | 0.470 |
Why?
|
Cell Adhesion | 9 | 2014 | 3102 | 0.450 |
Why?
|
Dogs | 23 | 2024 | 3846 | 0.450 |
Why?
|
Coated Materials, Biocompatible | 2 | 2014 | 311 | 0.420 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2014 | 2890 | 0.410 |
Why?
|
Angioscopy | 4 | 2000 | 47 | 0.410 |
Why?
|
Vascular Diseases | 8 | 2009 | 1161 | 0.400 |
Why?
|
Cell-Matrix Junctions | 1 | 2011 | 21 | 0.390 |
Why?
|
Foot Diseases | 6 | 1992 | 148 | 0.370 |
Why?
|
Thrombin | 7 | 2005 | 600 | 0.360 |
Why?
|
Diabetes Mellitus, Experimental | 3 | 2015 | 1122 | 0.360 |
Why?
|
Peripheral Arterial Disease | 2 | 2024 | 1303 | 0.350 |
Why?
|
Cell Movement | 8 | 2011 | 5215 | 0.340 |
Why?
|
Anastomosis, Surgical | 11 | 2007 | 993 | 0.330 |
Why?
|
Life Tables | 8 | 2017 | 368 | 0.330 |
Why?
|
Antithrombins | 4 | 2024 | 294 | 0.320 |
Why?
|
Microcirculation | 12 | 2002 | 1282 | 0.320 |
Why?
|
Substance P | 4 | 2015 | 332 | 0.300 |
Why?
|
Polyethylene Glycols | 1 | 2014 | 1195 | 0.300 |
Why?
|
Bacterial Infections | 4 | 2005 | 1397 | 0.280 |
Why?
|
Decision Support Techniques | 1 | 2017 | 2006 | 0.280 |
Why?
|
Intracranial Embolism | 1 | 2008 | 189 | 0.280 |
Why?
|
Foot Ulcer | 2 | 1999 | 62 | 0.270 |
Why?
|
Skin Ulcer | 4 | 2013 | 130 | 0.260 |
Why?
|
Device Approval | 1 | 2007 | 164 | 0.250 |
Why?
|
Leiomyomatosis | 1 | 2005 | 69 | 0.250 |
Why?
|
High-Throughput Screening Assays | 1 | 2011 | 937 | 0.250 |
Why?
|
Prosthesis-Related Infections | 2 | 2005 | 494 | 0.240 |
Why?
|
Coronary Vessels | 3 | 2012 | 3125 | 0.240 |
Why?
|
Diabetes Mellitus | 14 | 2011 | 5891 | 0.240 |
Why?
|
Muscle Proteins | 2 | 2001 | 1165 | 0.240 |
Why?
|
Arteriovenous Shunt, Surgical | 6 | 1992 | 291 | 0.230 |
Why?
|
Anti-Infective Agents | 4 | 2010 | 985 | 0.230 |
Why?
|
Gene Expression | 4 | 2004 | 7598 | 0.230 |
Why?
|
Vascular Neoplasms | 1 | 2005 | 167 | 0.230 |
Why?
|
Angioplasty, Balloon, Coronary | 2 | 2002 | 1724 | 0.230 |
Why?
|
Flow Cytometry | 2 | 2012 | 5900 | 0.220 |
Why?
|
Vena Cava, Inferior | 3 | 2005 | 463 | 0.220 |
Why?
|
Bandages | 1 | 2005 | 273 | 0.220 |
Why?
|
Cerebral Infarction | 1 | 2008 | 975 | 0.220 |
Why?
|
Serum Albumin, Bovine | 6 | 2002 | 320 | 0.220 |
Why?
|
Polyesters | 2 | 2010 | 376 | 0.210 |
Why?
|
Cerebrovascular Disorders | 4 | 1999 | 1486 | 0.210 |
Why?
|
Popliteal Vein | 3 | 2000 | 43 | 0.210 |
Why?
|
Coronary Disease | 4 | 2002 | 5924 | 0.210 |
Why?
|
Humans | 171 | 2024 | 768393 | 0.210 |
Why?
|
Surface Properties | 8 | 2005 | 1167 | 0.200 |
Why?
|
Femoral Vein | 3 | 2000 | 154 | 0.200 |
Why?
|
Cysteine Endopeptidases | 2 | 2001 | 542 | 0.200 |
Why?
|
Angioplasty, Balloon | 4 | 2016 | 592 | 0.200 |
Why?
|
Cadherins | 1 | 2007 | 906 | 0.200 |
Why?
|
Cell Proliferation | 7 | 2024 | 10478 | 0.200 |
Why?
|
Heart Neoplasms | 1 | 2005 | 374 | 0.200 |
Why?
|
Gelatin | 1 | 2024 | 231 | 0.200 |
Why?
|
Time Factors | 26 | 2017 | 40272 | 0.190 |
Why?
|
Neuropeptide Y | 3 | 2011 | 194 | 0.190 |
Why?
|
Multienzyme Complexes | 2 | 2001 | 665 | 0.190 |
Why?
|
Platelet Activation | 3 | 1995 | 644 | 0.180 |
Why?
|
Cell Division | 5 | 2002 | 4479 | 0.180 |
Why?
|
Blood Coagulation | 2 | 2005 | 1161 | 0.180 |
Why?
|
Arginine | 1 | 2024 | 923 | 0.180 |
Why?
|
Cells, Cultured | 12 | 2011 | 19022 | 0.180 |
Why?
|
Venous Cutdown | 1 | 2000 | 5 | 0.180 |
Why?
|
Vascular System Injuries | 1 | 2024 | 248 | 0.170 |
Why?
|
Cytokines | 3 | 2013 | 7445 | 0.170 |
Why?
|
Gene Expression Regulation | 6 | 2016 | 11918 | 0.170 |
Why?
|
Nuclear Proteins | 2 | 2014 | 5800 | 0.170 |
Why?
|
Coronary Artery Bypass | 2 | 2014 | 2194 | 0.170 |
Why?
|
Celiac Artery | 1 | 2000 | 65 | 0.170 |
Why?
|
Heel | 1 | 1999 | 38 | 0.170 |
Why?
|
Echocardiography, Transesophageal | 1 | 2005 | 1095 | 0.160 |
Why?
|
Aged | 68 | 2017 | 171562 | 0.160 |
Why?
|
Endothelial Cells | 3 | 2024 | 3587 | 0.160 |
Why?
|
Vasodilation | 6 | 2002 | 968 | 0.160 |
Why?
|
Estradiol Congeners | 1 | 1998 | 23 | 0.160 |
Why?
|
Certification | 1 | 2002 | 420 | 0.160 |
Why?
|
Animals | 42 | 2024 | 169337 | 0.150 |
Why?
|
RNA, Messenger | 7 | 2014 | 12805 | 0.150 |
Why?
|
Blood Flow Velocity | 7 | 1998 | 1376 | 0.150 |
Why?
|
DNA-Binding Proteins | 2 | 2014 | 9614 | 0.150 |
Why?
|
Staphylococcal Infections | 2 | 2005 | 1398 | 0.150 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2004 | 3794 | 0.150 |
Why?
|
Proteins | 3 | 2001 | 6006 | 0.150 |
Why?
|
Cell Count | 2 | 2012 | 1833 | 0.140 |
Why?
|
Rabbits | 6 | 2015 | 4781 | 0.140 |
Why?
|
Axillary Artery | 3 | 1992 | 48 | 0.140 |
Why?
|
Interleukin-8 | 2 | 2011 | 705 | 0.140 |
Why?
|
Heparin | 1 | 2024 | 1636 | 0.140 |
Why?
|
Heart Valve Prosthesis | 1 | 2005 | 1468 | 0.140 |
Why?
|
Recombinant Proteins | 8 | 2024 | 6510 | 0.140 |
Why?
|
Uterine Neoplasms | 1 | 2005 | 1427 | 0.140 |
Why?
|
Gastric Mucosa | 1 | 2000 | 602 | 0.140 |
Why?
|
Prostheses and Implants | 3 | 2010 | 1279 | 0.140 |
Why?
|
Inflammation | 3 | 2015 | 10863 | 0.130 |
Why?
|
Postoperative Complications | 20 | 2007 | 15881 | 0.130 |
Why?
|
Female | 89 | 2024 | 397089 | 0.130 |
Why?
|
Membrane Proteins | 3 | 2014 | 7880 | 0.130 |
Why?
|
Male | 86 | 2024 | 364902 | 0.130 |
Why?
|
Reoperation | 13 | 2007 | 4341 | 0.130 |
Why?
|
Diabetes Mellitus, Type 1 | 6 | 2003 | 3440 | 0.130 |
Why?
|
Carotid Artery Injuries | 1 | 2016 | 96 | 0.130 |
Why?
|
Models, Animal | 4 | 2007 | 2124 | 0.130 |
Why?
|
Extremities | 5 | 2004 | 870 | 0.130 |
Why?
|
Rheology | 6 | 1985 | 348 | 0.130 |
Why?
|
Regional Blood Flow | 6 | 2000 | 1502 | 0.130 |
Why?
|
Materials Testing | 4 | 2005 | 872 | 0.130 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2008 | 10377 | 0.130 |
Why?
|
Forearm | 6 | 2002 | 428 | 0.120 |
Why?
|
Retrospective Studies | 39 | 2017 | 81801 | 0.120 |
Why?
|
Gene Knockdown Techniques | 2 | 2024 | 1608 | 0.120 |
Why?
|
Skin | 8 | 2015 | 4499 | 0.120 |
Why?
|
Estrogen Replacement Therapy | 2 | 1999 | 1209 | 0.120 |
Why?
|
Receptors, Neurokinin-1 | 2 | 2015 | 133 | 0.120 |
Why?
|
Models, Anatomic | 3 | 1990 | 684 | 0.120 |
Why?
|
Carboxylic Acids | 4 | 2005 | 91 | 0.120 |
Why?
|
Methacrylates | 1 | 2015 | 110 | 0.120 |
Why?
|
Adsorption | 2 | 2014 | 198 | 0.120 |
Why?
|
Carotid Artery, Internal | 5 | 2003 | 445 | 0.120 |
Why?
|
Tissue Preservation | 3 | 1992 | 173 | 0.120 |
Why?
|
Follow-Up Studies | 23 | 2006 | 39407 | 0.110 |
Why?
|
Up-Regulation | 4 | 2013 | 4142 | 0.110 |
Why?
|
Actuarial Analysis | 5 | 1992 | 372 | 0.110 |
Why?
|
Methods | 10 | 1996 | 1067 | 0.110 |
Why?
|
Plant Lectins | 1 | 1993 | 103 | 0.110 |
Why?
|
Metatarsus | 1 | 1993 | 18 | 0.110 |
Why?
|
Ultrasonics | 3 | 1991 | 208 | 0.110 |
Why?
|
Glycoconjugates | 1 | 1993 | 88 | 0.110 |
Why?
|
Gangrene | 5 | 1999 | 92 | 0.110 |
Why?
|
Aged, 80 and over | 19 | 2007 | 59686 | 0.100 |
Why?
|
Interferon-gamma | 2 | 1999 | 3164 | 0.100 |
Why?
|
Endothelial Growth Factors | 3 | 2002 | 674 | 0.100 |
Why?
|
Hydrogen-Ion Concentration | 4 | 2015 | 2488 | 0.100 |
Why?
|
Cross-Linking Reagents | 4 | 1997 | 692 | 0.100 |
Why?
|
Wounds and Injuries | 1 | 2005 | 2514 | 0.100 |
Why?
|
Cell Shape | 1 | 2014 | 371 | 0.100 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2533 | 0.100 |
Why?
|
Microscopy, Electron, Scanning | 6 | 1995 | 946 | 0.100 |
Why?
|
Brachiocephalic Veins | 1 | 1992 | 21 | 0.100 |
Why?
|
Pulse | 2 | 1986 | 218 | 0.100 |
Why?
|
Kidney Failure, Chronic | 4 | 2004 | 2491 | 0.100 |
Why?
|
Lymphokines | 3 | 2002 | 927 | 0.100 |
Why?
|
Middle Aged | 60 | 2011 | 223491 | 0.100 |
Why?
|
Peripheral Nerves | 1 | 1996 | 492 | 0.100 |
Why?
|
Survival Analysis | 9 | 2007 | 10117 | 0.100 |
Why?
|
Receptors, Neuropeptide Y | 1 | 2011 | 47 | 0.100 |
Why?
|
Treatment Outcome | 20 | 2024 | 65379 | 0.100 |
Why?
|
Angiography | 7 | 1999 | 1598 | 0.100 |
Why?
|
Salvage Therapy | 3 | 2000 | 1277 | 0.100 |
Why?
|
Activities of Daily Living | 2 | 1998 | 2433 | 0.090 |
Why?
|
Tensile Strength | 3 | 2005 | 335 | 0.090 |
Why?
|
Blood Physiological Phenomena | 1 | 1991 | 53 | 0.090 |
Why?
|
Lectins | 1 | 1993 | 490 | 0.090 |
Why?
|
Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2010 | 5 | 0.090 |
Why?
|
Estrogens | 1 | 1998 | 1534 | 0.090 |
Why?
|
Protein Binding | 7 | 2001 | 9343 | 0.090 |
Why?
|
Diabetes Mellitus, Type 2 | 10 | 2003 | 12241 | 0.090 |
Why?
|
Genes | 1 | 1995 | 1824 | 0.090 |
Why?
|
Air Pressure | 1 | 2010 | 75 | 0.090 |
Why?
|
Nitroprusside | 6 | 2002 | 272 | 0.090 |
Why?
|
Tibial Arteries | 3 | 2002 | 60 | 0.090 |
Why?
|
Acetylcholine | 7 | 2002 | 629 | 0.090 |
Why?
|
General Surgery | 1 | 2002 | 1713 | 0.090 |
Why?
|
Photomicrography | 1 | 1990 | 72 | 0.090 |
Why?
|
Length of Stay | 7 | 2005 | 6519 | 0.090 |
Why?
|
Aortic Aneurysm | 2 | 2014 | 649 | 0.090 |
Why?
|
Indicators and Reagents | 1 | 2011 | 455 | 0.090 |
Why?
|
Alloxan | 1 | 2009 | 13 | 0.090 |
Why?
|
Life Expectancy | 1 | 2017 | 1249 | 0.090 |
Why?
|
Survival Rate | 11 | 2005 | 12870 | 0.090 |
Why?
|
Blood Circulation | 2 | 1981 | 248 | 0.090 |
Why?
|
Inflammation Mediators | 3 | 2014 | 1890 | 0.080 |
Why?
|
Carotid Artery Diseases | 4 | 2003 | 878 | 0.080 |
Why?
|
Fluorescence | 1 | 2012 | 759 | 0.080 |
Why?
|
Risk Factors | 20 | 2024 | 74962 | 0.080 |
Why?
|
Creatinine | 3 | 2006 | 1915 | 0.080 |
Why?
|
Tissue Culture Techniques | 1 | 2010 | 290 | 0.080 |
Why?
|
Aneurysm | 2 | 2004 | 343 | 0.080 |
Why?
|
Prosthesis Design | 4 | 1998 | 2126 | 0.080 |
Why?
|
Quality Control | 1 | 2012 | 833 | 0.080 |
Why?
|
Thrombophlebitis | 2 | 1989 | 289 | 0.080 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2011 | 462 | 0.080 |
Why?
|
Iontophoresis | 5 | 2001 | 75 | 0.080 |
Why?
|
Textiles | 3 | 2010 | 45 | 0.080 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 1991 | 170 | 0.080 |
Why?
|
Surgical Instruments | 1 | 1991 | 386 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 4588 | 0.080 |
Why?
|
Tissue Scaffolds | 1 | 2015 | 950 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6541 | 0.080 |
Why?
|
Monitoring, Intraoperative | 2 | 1993 | 950 | 0.070 |
Why?
|
Growth Substances | 2 | 2014 | 761 | 0.070 |
Why?
|
Disease-Free Survival | 2 | 2017 | 6856 | 0.070 |
Why?
|
Macrophages | 4 | 2016 | 5796 | 0.070 |
Why?
|
Cloning, Molecular | 3 | 1999 | 4168 | 0.070 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2008 | 317 | 0.070 |
Why?
|
Analgesia, Epidural | 1 | 1991 | 332 | 0.070 |
Why?
|
Platelet Aggregation | 4 | 1991 | 769 | 0.070 |
Why?
|
Calcinosis | 1 | 1996 | 1481 | 0.070 |
Why?
|
Hyperglycemia | 2 | 2011 | 1389 | 0.070 |
Why?
|
Diabetic Nephropathies | 1 | 1994 | 975 | 0.070 |
Why?
|
Rats, Wistar | 2 | 2015 | 1890 | 0.070 |
Why?
|
Inguinal Canal | 2 | 2005 | 71 | 0.070 |
Why?
|
Hemodynamics | 5 | 1998 | 4199 | 0.070 |
Why?
|
Porosity | 2 | 2015 | 351 | 0.070 |
Why?
|
Molecular Chaperones | 2 | 2001 | 762 | 0.070 |
Why?
|
Blotting, Northern | 3 | 1998 | 1553 | 0.070 |
Why?
|
Voluntary Health Agencies | 1 | 1986 | 38 | 0.070 |
Why?
|
Blood Platelets | 3 | 1995 | 2476 | 0.070 |
Why?
|
Transplantation, Autologous | 8 | 2000 | 2127 | 0.070 |
Why?
|
Quality of Health Care | 2 | 2009 | 4339 | 0.070 |
Why?
|
Oxygen | 2 | 2015 | 4273 | 0.060 |
Why?
|
Aorta, Abdominal | 5 | 1995 | 627 | 0.060 |
Why?
|
Ultrasonography | 6 | 1996 | 6001 | 0.060 |
Why?
|
Contusions | 1 | 1986 | 78 | 0.060 |
Why?
|
Blotting, Western | 2 | 2007 | 5037 | 0.060 |
Why?
|
Ethylenediamines | 1 | 2005 | 57 | 0.060 |
Why?
|
Iliac Artery | 2 | 1985 | 344 | 0.060 |
Why?
|
Proteasome Endopeptidase Complex | 3 | 2001 | 1319 | 0.060 |
Why?
|
Intraoperative Care | 4 | 2000 | 771 | 0.060 |
Why?
|
Cell Death | 1 | 2011 | 1682 | 0.060 |
Why?
|
Spectrophotometry | 1 | 2005 | 292 | 0.060 |
Why?
|
Heart Atria | 1 | 2011 | 1360 | 0.060 |
Why?
|
Immunohistochemistry | 6 | 2002 | 11120 | 0.060 |
Why?
|
Methylene Blue | 1 | 2005 | 156 | 0.060 |
Why?
|
Adult | 38 | 2006 | 223640 | 0.060 |
Why?
|
Prosthesis Failure | 4 | 2001 | 1208 | 0.060 |
Why?
|
Polymers | 2 | 2005 | 1630 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 3813 | 0.060 |
Why?
|
Transplantation | 1 | 1986 | 221 | 0.060 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2024 | 79 | 0.060 |
Why?
|
Cell-Penetrating Peptides | 1 | 2024 | 44 | 0.060 |
Why?
|
Fibrinolytic Agents | 1 | 1994 | 2074 | 0.060 |
Why?
|
Radiography | 9 | 2004 | 6993 | 0.060 |
Why?
|
Spasm | 1 | 1984 | 131 | 0.060 |
Why?
|
Critical Illness | 1 | 2017 | 2755 | 0.060 |
Why?
|
Heart Function Tests | 1 | 2005 | 318 | 0.060 |
Why?
|
Pipecolic Acids | 1 | 2024 | 77 | 0.060 |
Why?
|
Neovascularization, Physiologic | 1 | 2011 | 1371 | 0.060 |
Why?
|
Physician-Patient Relations | 1 | 2017 | 3267 | 0.060 |
Why?
|
Glycoproteins | 2 | 2001 | 2204 | 0.060 |
Why?
|
Computational Biology | 1 | 2016 | 3543 | 0.060 |
Why?
|
beta 2-Microglobulin | 1 | 2024 | 329 | 0.050 |
Why?
|
Models, Chemical | 1 | 2005 | 611 | 0.050 |
Why?
|
Vascular Endothelial Growth Factors | 3 | 2002 | 750 | 0.050 |
Why?
|
Molecular Sequence Data | 4 | 1999 | 17626 | 0.050 |
Why?
|
Infection Control | 1 | 2010 | 985 | 0.050 |
Why?
|
Polyethylenes | 1 | 2005 | 290 | 0.050 |
Why?
|
Fluorescent Dyes | 1 | 2011 | 1926 | 0.050 |
Why?
|
Chromans | 1 | 2003 | 117 | 0.050 |
Why?
|
Communication | 1 | 2017 | 3912 | 0.050 |
Why?
|
Vasodilator Agents | 4 | 2002 | 990 | 0.050 |
Why?
|
Lasers | 1 | 1987 | 952 | 0.050 |
Why?
|
Brachial Artery | 3 | 1998 | 373 | 0.050 |
Why?
|
Coloring Agents | 3 | 2010 | 564 | 0.050 |
Why?
|
Cattle | 3 | 1999 | 3826 | 0.050 |
Why?
|
Mesenteric Artery, Superior | 1 | 2002 | 96 | 0.050 |
Why?
|
Graft Survival | 5 | 2005 | 3900 | 0.050 |
Why?
|
Registries | 7 | 2005 | 8379 | 0.050 |
Why?
|
Adenosine Triphosphate | 3 | 1995 | 2002 | 0.050 |
Why?
|
Blood Vessels | 3 | 1985 | 1110 | 0.050 |
Why?
|
Rats | 3 | 2024 | 23835 | 0.050 |
Why?
|
Credentialing | 1 | 2002 | 114 | 0.050 |
Why?
|
Complement Inactivator Proteins | 1 | 2001 | 74 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-sis | 2 | 2001 | 254 | 0.050 |
Why?
|
Health Services Research | 1 | 2009 | 1817 | 0.050 |
Why?
|
Disease Models, Animal | 4 | 2009 | 18362 | 0.050 |
Why?
|
Recurrence | 4 | 2002 | 8506 | 0.050 |
Why?
|
Endocarditis, Bacterial | 1 | 2005 | 436 | 0.050 |
Why?
|
MicroRNAs | 1 | 2017 | 3804 | 0.050 |
Why?
|
Tissue and Organ Harvesting | 1 | 2024 | 374 | 0.050 |
Why?
|
Cell Cycle | 2 | 2007 | 2938 | 0.050 |
Why?
|
Chi-Square Distribution | 3 | 2005 | 3438 | 0.050 |
Why?
|
Iliac Aneurysm | 1 | 2001 | 37 | 0.050 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2002 | 427 | 0.040 |
Why?
|
Down-Regulation | 2 | 2013 | 2940 | 0.040 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 2 | 1999 | 692 | 0.040 |
Why?
|
Platelet-Derived Growth Factor | 2 | 2001 | 617 | 0.040 |
Why?
|
Statistics, Nonparametric | 2 | 1996 | 2862 | 0.040 |
Why?
|
Forefoot, Human | 1 | 1999 | 31 | 0.040 |
Why?
|
Extracellular Matrix | 2 | 2001 | 1739 | 0.040 |
Why?
|
Thiazolidinediones | 1 | 2003 | 462 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2009 | 3230 | 0.040 |
Why?
|
Nitric Oxide Synthase | 2 | 2002 | 911 | 0.040 |
Why?
|
Videotape Recording | 2 | 1991 | 336 | 0.040 |
Why?
|
Enzyme Activation | 2 | 2002 | 3587 | 0.040 |
Why?
|
Diffusion of Innovation | 1 | 2024 | 732 | 0.040 |
Why?
|
Vasomotor System | 1 | 1999 | 208 | 0.040 |
Why?
|
Reflex | 1 | 2001 | 375 | 0.040 |
Why?
|
Transforming Growth Factor alpha | 1 | 1999 | 135 | 0.040 |
Why?
|
Microscopy, Electron | 3 | 1992 | 2559 | 0.040 |
Why?
|
Antibodies | 1 | 2007 | 2425 | 0.040 |
Why?
|
Ischemic Attack, Transient | 2 | 2003 | 877 | 0.040 |
Why?
|
Heart Failure | 5 | 2011 | 11858 | 0.040 |
Why?
|
Retinoblastoma Protein | 1 | 2002 | 673 | 0.040 |
Why?
|
Chemotaxis | 1 | 2001 | 600 | 0.040 |
Why?
|
Incidence | 4 | 2002 | 21544 | 0.040 |
Why?
|
Endoscopy | 3 | 1995 | 1857 | 0.040 |
Why?
|
Tyrosine | 1 | 2002 | 1428 | 0.040 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2000 | 254 | 0.040 |
Why?
|
Specialty Boards | 1 | 2000 | 236 | 0.040 |
Why?
|
Atherosclerosis | 1 | 2014 | 3431 | 0.040 |
Why?
|
Platelet Count | 2 | 1991 | 784 | 0.040 |
Why?
|
Laser-Doppler Flowmetry | 1 | 1998 | 238 | 0.040 |
Why?
|
Polycarboxylate Cement | 1 | 1997 | 18 | 0.040 |
Why?
|
Organ Preservation | 1 | 1981 | 390 | 0.040 |
Why?
|
Drug Stability | 1 | 1998 | 291 | 0.040 |
Why?
|
History, 21st Century | 1 | 2024 | 1575 | 0.040 |
Why?
|
Thrombosis | 8 | 1999 | 2955 | 0.040 |
Why?
|
Treatment Failure | 2 | 1995 | 2663 | 0.040 |
Why?
|
Intraoperative Period | 2 | 1990 | 513 | 0.040 |
Why?
|
Biological Availability | 1 | 1998 | 392 | 0.040 |
Why?
|
Logistic Models | 6 | 2006 | 13323 | 0.040 |
Why?
|
DNA Probes | 1 | 1998 | 542 | 0.040 |
Why?
|
Manometry | 1 | 2000 | 459 | 0.040 |
Why?
|
Wrist | 1 | 1979 | 232 | 0.040 |
Why?
|
Bioprosthesis | 1 | 1981 | 592 | 0.040 |
Why?
|
Iodine Radioisotopes | 1 | 2001 | 1035 | 0.040 |
Why?
|
Cytoplasm | 1 | 2001 | 1502 | 0.030 |
Why?
|
Maleimides | 1 | 1997 | 112 | 0.030 |
Why?
|
Mitral Valve | 1 | 2005 | 1474 | 0.030 |
Why?
|
Risk Assessment | 2 | 2017 | 24318 | 0.030 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 1999 | 595 | 0.030 |
Why?
|
Ubiquitin | 1 | 2001 | 842 | 0.030 |
Why?
|
Rehabilitation Centers | 1 | 1998 | 249 | 0.030 |
Why?
|
Residence Characteristics | 2 | 1998 | 2122 | 0.030 |
Why?
|
Cell Adhesion Molecules | 2 | 1999 | 1614 | 0.030 |
Why?
|
Morbidity | 2 | 2003 | 1758 | 0.030 |
Why?
|
United States | 7 | 2009 | 73150 | 0.030 |
Why?
|
Severity of Illness Index | 4 | 2006 | 15939 | 0.030 |
Why?
|
Tissue Donors | 1 | 1986 | 2389 | 0.030 |
Why?
|
Vertebral Artery | 1 | 1977 | 185 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2000 | 1104 | 0.030 |
Why?
|
Models, Biological | 3 | 1982 | 9493 | 0.030 |
Why?
|
Sphincter of Oddi | 1 | 1975 | 21 | 0.030 |
Why?
|
Homes for the Aged | 1 | 1998 | 273 | 0.030 |
Why?
|
Cohort Studies | 8 | 2005 | 41795 | 0.030 |
Why?
|
History, 20th Century | 1 | 2024 | 2771 | 0.030 |
Why?
|
Base Sequence | 2 | 1999 | 12422 | 0.030 |
Why?
|
Hemostasis, Surgical | 1 | 1996 | 127 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2007 | 4357 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2014 | 20224 | 0.030 |
Why?
|
Endothelium | 3 | 1983 | 768 | 0.030 |
Why?
|
Thiazoles | 1 | 2003 | 1542 | 0.030 |
Why?
|
Staphylococcus aureus | 2 | 1993 | 1429 | 0.030 |
Why?
|
GATA4 Transcription Factor | 1 | 2016 | 125 | 0.030 |
Why?
|
Models, Cardiovascular | 1 | 1980 | 984 | 0.030 |
Why?
|
Aorta, Thoracic | 2 | 1999 | 1112 | 0.030 |
Why?
|
Ampulla of Vater | 1 | 1975 | 150 | 0.030 |
Why?
|
Intestinal Polyps | 1 | 1975 | 105 | 0.030 |
Why?
|
Biliary Tract Diseases | 1 | 1975 | 159 | 0.030 |
Why?
|
Hyperbaric Oxygenation | 1 | 1996 | 166 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2006 | 3857 | 0.030 |
Why?
|
Ethics, Medical | 1 | 2000 | 785 | 0.030 |
Why?
|
Medicare | 1 | 1993 | 6881 | 0.030 |
Why?
|
Menstrual Cycle | 1 | 1998 | 545 | 0.030 |
Why?
|
Chromogenic Compounds | 1 | 1994 | 30 | 0.030 |
Why?
|
Evaluation Studies as Topic | 3 | 1999 | 1629 | 0.030 |
Why?
|
Decompression, Surgical | 1 | 2000 | 610 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 2 | 2005 | 2258 | 0.030 |
Why?
|
Phenotype | 2 | 2008 | 16721 | 0.030 |
Why?
|
Sulfonamides | 1 | 2024 | 1980 | 0.030 |
Why?
|
Kidney Transplantation | 3 | 2003 | 4300 | 0.030 |
Why?
|
Ophthalmic Artery | 1 | 1974 | 58 | 0.030 |
Why?
|
Protein Biosynthesis | 1 | 2001 | 2094 | 0.030 |
Why?
|
Hematoma | 1 | 1999 | 768 | 0.030 |
Why?
|
Blood Cell Count | 1 | 1995 | 402 | 0.030 |
Why?
|
alpha 1-Antitrypsin | 1 | 1995 | 169 | 0.030 |
Why?
|
Cyclins | 1 | 1996 | 606 | 0.030 |
Why?
|
Plasminogen | 1 | 1994 | 144 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2002 | 3520 | 0.030 |
Why?
|
Serum Albumin | 1 | 1997 | 676 | 0.030 |
Why?
|
Chromatography, Gel | 1 | 1994 | 637 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1995 | 1056 | 0.030 |
Why?
|
Hydrolysis | 1 | 1995 | 646 | 0.030 |
Why?
|
Papaverine | 2 | 1984 | 45 | 0.030 |
Why?
|
Drug Interactions | 1 | 1998 | 1420 | 0.030 |
Why?
|
Stroke Volume | 1 | 2007 | 5619 | 0.030 |
Why?
|
Biomedical Research | 1 | 2009 | 3464 | 0.030 |
Why?
|
Myocardial Infarction | 4 | 2005 | 11516 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2015 | 669 | 0.030 |
Why?
|
Syndrome | 1 | 2000 | 3275 | 0.030 |
Why?
|
Renal Dialysis | 5 | 2006 | 1802 | 0.030 |
Why?
|
Perfusion | 1 | 1998 | 1402 | 0.030 |
Why?
|
Growth Inhibitors | 1 | 2014 | 375 | 0.030 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2016 | 633 | 0.030 |
Why?
|
Amputation Stumps | 1 | 1993 | 38 | 0.030 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 1993 | 199 | 0.030 |
Why?
|
Quality of Life | 1 | 1995 | 13503 | 0.030 |
Why?
|
Sulfhydryl Compounds | 1 | 1994 | 296 | 0.030 |
Why?
|
Creatine Kinase | 1 | 1995 | 685 | 0.030 |
Why?
|
Axons | 1 | 2001 | 1678 | 0.030 |
Why?
|
Finite Element Analysis | 1 | 2015 | 442 | 0.030 |
Why?
|
Case-Control Studies | 4 | 1999 | 22296 | 0.030 |
Why?
|
Intraoperative Complications | 2 | 2007 | 1176 | 0.030 |
Why?
|
Collagen | 2 | 2016 | 2646 | 0.030 |
Why?
|
Ileum | 1 | 1975 | 558 | 0.030 |
Why?
|
Intestinal Neoplasms | 1 | 1975 | 316 | 0.030 |
Why?
|
Bacterial Adhesion | 1 | 1993 | 305 | 0.020 |
Why?
|
Leg Injuries | 2 | 1985 | 180 | 0.020 |
Why?
|
Retinoblastoma | 1 | 1995 | 321 | 0.020 |
Why?
|
Autoantigens | 1 | 1996 | 891 | 0.020 |
Why?
|
Dipeptides | 1 | 1994 | 386 | 0.020 |
Why?
|
Interleukin-1 | 1 | 2016 | 1251 | 0.020 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2002 | 1252 | 0.020 |
Why?
|
Intermittent Claudication | 3 | 2000 | 305 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 2 | 2001 | 1961 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2024 | 5151 | 0.020 |
Why?
|
Peptide Hydrolases | 1 | 2014 | 610 | 0.020 |
Why?
|
DNA, Complementary | 1 | 1995 | 1992 | 0.020 |
Why?
|
Hot Temperature | 2 | 1998 | 1440 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2024 | 9510 | 0.020 |
Why?
|
Genetic Techniques | 1 | 2014 | 428 | 0.020 |
Why?
|
Clusterin | 2 | 2001 | 72 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 1994 | 13423 | 0.020 |
Why?
|
Patient Admission | 1 | 1998 | 1367 | 0.020 |
Why?
|
Filtration | 2 | 1982 | 228 | 0.020 |
Why?
|
Protease Inhibitors | 1 | 2014 | 752 | 0.020 |
Why?
|
Radiology, Interventional | 1 | 1995 | 483 | 0.020 |
Why?
|
Geriatric Assessment | 1 | 1998 | 1422 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1994 | 1539 | 0.020 |
Why?
|
Nursing Homes | 1 | 1998 | 1084 | 0.020 |
Why?
|
Thromboxane B2 | 1 | 1990 | 143 | 0.020 |
Why?
|
Heart Diseases | 2 | 2004 | 2819 | 0.020 |
Why?
|
Renal Insufficiency | 1 | 1996 | 809 | 0.020 |
Why?
|
Chemical Industry | 1 | 2010 | 117 | 0.020 |
Why?
|
Boston | 3 | 2004 | 9371 | 0.020 |
Why?
|
Postoperative Period | 2 | 2006 | 1830 | 0.020 |
Why?
|
Fibrinolysis | 1 | 1991 | 331 | 0.020 |
Why?
|
Platelet Adhesiveness | 1 | 1990 | 154 | 0.020 |
Why?
|
Substrate Specificity | 1 | 1994 | 1753 | 0.020 |
Why?
|
Therapeutic Irrigation | 1 | 1991 | 297 | 0.020 |
Why?
|
Prospective Studies | 6 | 2006 | 54920 | 0.020 |
Why?
|
Dermis | 1 | 2011 | 203 | 0.020 |
Why?
|
Cell Survival | 2 | 2015 | 5792 | 0.020 |
Why?
|
Protein Kinase C | 1 | 2014 | 1207 | 0.020 |
Why?
|
Tissue Engineering | 2 | 2015 | 1891 | 0.020 |
Why?
|
Stroke | 3 | 2003 | 9742 | 0.020 |
Why?
|
Transcription, Genetic | 3 | 2002 | 7599 | 0.020 |
Why?
|
Cause of Death | 1 | 2000 | 3728 | 0.020 |
Why?
|
Anticoagulants | 2 | 2024 | 4843 | 0.020 |
Why?
|
Fiber Optic Technology | 1 | 1991 | 291 | 0.020 |
Why?
|
Transcription Factors | 2 | 2014 | 12166 | 0.020 |
Why?
|
Sex Factors | 2 | 2000 | 10654 | 0.020 |
Why?
|
Thrombectomy | 1 | 1994 | 671 | 0.020 |
Why?
|
Smoking | 2 | 2000 | 9111 | 0.020 |
Why?
|
Hemostasis | 1 | 1991 | 468 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2000 | 3048 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2016 | 2003 | 0.020 |
Why?
|
Oligopeptides | 1 | 1994 | 1194 | 0.020 |
Why?
|
Reference Values | 3 | 2002 | 4941 | 0.020 |
Why?
|
Cell Cycle Proteins | 2 | 2014 | 3458 | 0.020 |
Why?
|
Genomics | 1 | 2004 | 5916 | 0.020 |
Why?
|
Random Allocation | 1 | 1992 | 2397 | 0.020 |
Why?
|
Risk | 2 | 1999 | 9636 | 0.020 |
Why?
|
Solubility | 2 | 1999 | 1085 | 0.020 |
Why?
|
Capillaries | 1 | 1991 | 756 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 1975 | 1280 | 0.020 |
Why?
|
Reimbursement Mechanisms | 1 | 1993 | 677 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 1993 | 1669 | 0.020 |
Why?
|
Microvessels | 1 | 2011 | 586 | 0.020 |
Why?
|
Colon | 1 | 1975 | 1805 | 0.020 |
Why?
|
Kinetics | 1 | 1994 | 6333 | 0.020 |
Why?
|
Age Factors | 2 | 2000 | 18471 | 0.020 |
Why?
|
Necrosis | 1 | 1990 | 1621 | 0.020 |
Why?
|
Anesthesia | 1 | 1997 | 1596 | 0.020 |
Why?
|
von Willebrand Factor | 2 | 1999 | 680 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 1995 | 6085 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 1991 | 3055 | 0.020 |
Why?
|
Binding Sites | 1 | 1994 | 6017 | 0.020 |
Why?
|
Obesity | 1 | 2007 | 13084 | 0.020 |
Why?
|
Research Support as Topic | 1 | 2009 | 696 | 0.010 |
Why?
|
Immunologic Factors | 1 | 2014 | 1597 | 0.010 |
Why?
|
Retroperitoneal Space | 1 | 1985 | 173 | 0.010 |
Why?
|
Suture Techniques | 1 | 1989 | 777 | 0.010 |
Why?
|
Cell Membrane | 1 | 2014 | 3663 | 0.010 |
Why?
|
Surgical Equipment | 1 | 1984 | 57 | 0.010 |
Why?
|
Fasting | 2 | 2003 | 1610 | 0.010 |
Why?
|
Ankle | 2 | 1978 | 354 | 0.010 |
Why?
|
Ureteral Obstruction | 1 | 1986 | 297 | 0.010 |
Why?
|
Fibula | 1 | 1986 | 270 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2001 | 11668 | 0.010 |
Why?
|
Arm Injuries | 1 | 1985 | 156 | 0.010 |
Why?
|
Patient Selection | 1 | 1996 | 4266 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1992 | 6241 | 0.010 |
Why?
|
Proteinuria | 1 | 2006 | 613 | 0.010 |
Why?
|
Computers | 1 | 1986 | 592 | 0.010 |
Why?
|
Mice | 3 | 2015 | 82017 | 0.010 |
Why?
|
Leg Ulcer | 2 | 1997 | 71 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 3666 | 0.010 |
Why?
|
Protein Conformation | 1 | 1991 | 3955 | 0.010 |
Why?
|
Hospital Mortality | 1 | 1997 | 5367 | 0.010 |
Why?
|
Blood Pressure | 5 | 1978 | 8541 | 0.010 |
Why?
|
Prognosis | 4 | 2006 | 30022 | 0.010 |
Why?
|
Venae Cavae | 1 | 1982 | 41 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2014 | 2237 | 0.010 |
Why?
|
Los Angeles | 1 | 2002 | 245 | 0.010 |
Why?
|
E2F1 Transcription Factor | 1 | 2002 | 182 | 0.010 |
Why?
|
Nuclear Matrix | 1 | 2001 | 30 | 0.010 |
Why?
|
Buffers | 1 | 2001 | 143 | 0.010 |
Why?
|
E2F Transcription Factors | 1 | 2002 | 270 | 0.010 |
Why?
|
Textile Industry | 1 | 2001 | 74 | 0.010 |
Why?
|
Health Status | 1 | 1995 | 4094 | 0.010 |
Why?
|
Immunoglobulins | 1 | 1984 | 855 | 0.010 |
Why?
|
Myocardial Revascularization | 1 | 2005 | 796 | 0.010 |
Why?
|
Signal Transduction | 1 | 2024 | 23631 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2008 | 36849 | 0.010 |
Why?
|
Umbilical Veins | 1 | 2001 | 425 | 0.010 |
Why?
|
Neutrophils | 1 | 1993 | 3785 | 0.010 |
Why?
|
Canada | 1 | 1986 | 2139 | 0.010 |
Why?
|
Tibia | 1 | 1986 | 1075 | 0.010 |
Why?
|
Cytomegalovirus | 1 | 1984 | 754 | 0.010 |
Why?
|
Hypertension | 1 | 2000 | 8615 | 0.010 |
Why?
|
Pulmonary Embolism | 3 | 1982 | 2587 | 0.010 |
Why?
|
Culture Media | 1 | 1981 | 898 | 0.010 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2002 | 706 | 0.010 |
Why?
|
Sodium Chloride | 1 | 1981 | 584 | 0.010 |
Why?
|
Adolescent | 6 | 2004 | 89184 | 0.010 |
Why?
|
Equipment Failure Analysis | 1 | 2001 | 848 | 0.010 |
Why?
|
Massachusetts | 1 | 1992 | 8902 | 0.010 |
Why?
|
Aneurysm, Ruptured | 1 | 2004 | 462 | 0.010 |
Why?
|
Immunoblotting | 1 | 2002 | 1647 | 0.010 |
Why?
|
Equipment and Supplies | 1 | 1981 | 273 | 0.010 |
Why?
|
Patient Readmission | 1 | 1993 | 3312 | 0.010 |
Why?
|
Biopsy | 2 | 2002 | 6808 | 0.010 |
Why?
|
Placebos | 1 | 2003 | 1668 | 0.010 |
Why?
|
Peroneal Nerve | 1 | 1998 | 80 | 0.010 |
Why?
|
Ethyldimethylaminopropyl Carbodiimide | 1 | 1997 | 6 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2014 | 8051 | 0.010 |
Why?
|
Butylene Glycols | 1 | 1997 | 11 | 0.010 |
Why?
|
Hydroxy Acids | 1 | 1997 | 19 | 0.010 |
Why?
|
Endothelin-1 | 1 | 1999 | 296 | 0.010 |
Why?
|
Pliability | 1 | 1997 | 58 | 0.010 |
Why?
|
Chemistry, Physical | 1 | 1997 | 153 | 0.010 |
Why?
|
Delayed-Action Preparations | 1 | 2001 | 969 | 0.010 |
Why?
|
Doppler Effect | 1 | 1977 | 12 | 0.010 |
Why?
|
Fibronectins | 1 | 2001 | 724 | 0.010 |
Why?
|
Proportional Hazards Models | 2 | 2005 | 12558 | 0.010 |
Why?
|
Subclavian Steal Syndrome | 1 | 1977 | 20 | 0.010 |
Why?
|
Chemical Phenomena | 1 | 1997 | 486 | 0.010 |
Why?
|
Extracellular Matrix Proteins | 1 | 2001 | 835 | 0.010 |
Why?
|
Pressure | 1 | 1980 | 1172 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2009 | 3707 | 0.010 |
Why?
|
Neural Conduction | 1 | 1998 | 443 | 0.010 |
Why?
|
Propionates | 1 | 1997 | 180 | 0.010 |
Why?
|
Societies, Medical | 1 | 2009 | 3960 | 0.010 |
Why?
|
Receptors, Immunologic | 1 | 2002 | 1416 | 0.010 |
Why?
|
Ultrasonography, Doppler | 1 | 1998 | 463 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2002 | 2363 | 0.010 |
Why?
|
Blood Viscosity | 1 | 1976 | 125 | 0.010 |
Why?
|
Antigens, Nuclear | 1 | 1996 | 183 | 0.010 |
Why?
|
Health Care Costs | 1 | 2009 | 3267 | 0.010 |
Why?
|
Membranes, Artificial | 1 | 1997 | 367 | 0.010 |
Why?
|
Ulcer | 1 | 1977 | 203 | 0.010 |
Why?
|
Ultrasonography, Interventional | 1 | 2004 | 1525 | 0.010 |
Why?
|
Preoperative Care | 1 | 2005 | 2258 | 0.010 |
Why?
|
Albuminuria | 1 | 1999 | 658 | 0.010 |
Why?
|
Forecasting | 1 | 2005 | 2948 | 0.010 |
Why?
|
Elasticity | 1 | 1997 | 657 | 0.010 |
Why?
|
Permeability | 1 | 1997 | 726 | 0.010 |
Why?
|
Premenopause | 1 | 1999 | 1039 | 0.010 |
Why?
|
Specialties, Surgical | 1 | 2000 | 393 | 0.010 |
Why?
|
Blood | 1 | 1997 | 597 | 0.010 |
Why?
|
Temperature | 1 | 1981 | 2235 | 0.010 |
Why?
|
Anesthesia, Epidural | 1 | 1997 | 232 | 0.010 |
Why?
|
Surgical Wound Infection | 1 | 2004 | 1545 | 0.010 |
Why?
|
Embolism | 1 | 1978 | 401 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 1984 | 2337 | 0.010 |
Why?
|
Ki-67 Antigen | 1 | 1996 | 628 | 0.010 |
Why?
|
Endarterectomy | 1 | 1974 | 196 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2001 | 1667 | 0.010 |
Why?
|
Anesthesia, Spinal | 1 | 1997 | 282 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2002 | 2886 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1998 | 1169 | 0.010 |
Why?
|
Motor Neurons | 1 | 1998 | 872 | 0.010 |
Why?
|
Anesthesia, General | 2 | 1997 | 1186 | 0.010 |
Why?
|
Graft Rejection | 1 | 1986 | 4505 | 0.010 |
Why?
|
Confidence Intervals | 1 | 1998 | 2931 | 0.010 |
Why?
|
Disease Progression | 2 | 2002 | 13646 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 2004 | 1946 | 0.010 |
Why?
|
Stress, Mechanical | 1 | 1997 | 1680 | 0.010 |
Why?
|
Duodenum | 1 | 1975 | 495 | 0.010 |
Why?
|
Myocardial Contraction | 1 | 1977 | 1527 | 0.010 |
Why?
|
Pneumonia | 1 | 2004 | 2163 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2002 | 4250 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2009 | 7453 | 0.010 |
Why?
|
Neuralgia | 1 | 1998 | 622 | 0.010 |
Why?
|
Ethanol | 1 | 1997 | 1332 | 0.010 |
Why?
|
Water | 1 | 1997 | 1418 | 0.010 |
Why?
|
Surgery, Plastic | 1 | 1978 | 650 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2000 | 2708 | 0.010 |
Why?
|
Postmenopause | 1 | 1999 | 2518 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2002 | 10776 | 0.010 |
Why?
|
Wounds, Gunshot | 1 | 1976 | 588 | 0.010 |
Why?
|
Body Mass Index | 1 | 2007 | 13052 | 0.010 |
Why?
|
Comorbidity | 1 | 2004 | 10588 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2002 | 12092 | 0.000 |
Why?
|
Insulin | 1 | 2003 | 6607 | 0.000 |
Why?
|
Acute Disease | 1 | 1998 | 7242 | 0.000 |
Why?
|
RNA | 1 | 1997 | 2726 | 0.000 |
Why?
|
Glucose | 1 | 1998 | 4352 | 0.000 |
Why?
|
Odds Ratio | 1 | 1998 | 9682 | 0.000 |
Why?
|
Predictive Value of Tests | 1 | 2002 | 15455 | 0.000 |
Why?
|
Hemagglutination Tests | 1 | 1984 | 76 | 0.000 |
Why?
|
Dilatation | 1 | 1986 | 313 | 0.000 |
Why?
|
Algorithms | 1 | 2005 | 14154 | 0.000 |
Why?
|
Pain | 1 | 1977 | 5103 | 0.000 |
Why?
|
Catheterization | 1 | 1986 | 1431 | 0.000 |
Why?
|
Jugular Veins | 1 | 1981 | 211 | 0.000 |
Why?
|
Cytomegalovirus Infections | 1 | 1984 | 839 | 0.000 |
Why?
|
Constriction | 1 | 1977 | 168 | 0.000 |
Why?
|
Fluoroscopy | 1 | 1981 | 952 | 0.000 |
Why?
|
Blood Volume | 1 | 1977 | 546 | 0.000 |
Why?
|
Cardiac Output | 1 | 1977 | 838 | 0.000 |
Why?
|
Wounds, Penetrating | 1 | 1976 | 315 | 0.000 |
Why?
|
Neoplasms | 1 | 1982 | 22385 | 0.000 |
Why?
|
Antibodies, Viral | 1 | 1984 | 3211 | 0.000 |
Why?
|
Hypotension | 1 | 1977 | 889 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1986 | 13020 | 0.000 |
Why?
|
Fractures, Bone | 1 | 1982 | 2062 | 0.000 |
Why?
|
Child | 2 | 1983 | 80891 | 0.000 |
Why?
|
Infant | 1 | 1983 | 36510 | 0.000 |
Why?
|
Child, Preschool | 1 | 1983 | 42650 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 1977 | 15649 | 0.000 |
Why?
|